ESMO OPEN, cilt.10, sa.3, ss.23-24, 2025 (SCI-Expanded, Scopus)
Background: Head and neck soft tissue sarcomas (HNSTS) are a group of rare heterogeneous
tumours arising from embryonic mesoderm. They comprise <1% of all
head and neck malignancies and 5e15% of all sarcomas with most head and neck
sarcomas arising from soft tissues. As a result, the prognostic determinants of this
disease have not yet been fully elucidated. This study aimed to examine the prognostic
indicators and oncological outcomes associated with HNSTS.
Methods: Between 2014 and 20019, the medical records of 51 adult patients were
retrospectively evaluated. Potential prognostic factors were analyzed in relation to
overall survival (OS) and disease-free survival (DFS). Univariate and multivariate analyses
were conducted using the Cox proportional hazards model to identify clinicopathologic
factors associated with DFS and OS.
Results: Rhabdomyosarcoma was the most prevalent tumor type (24%), followed by
angiosarcoma (14%). The majority of the patients received treatment with the
doxorubicin and ifosfamide protocol. At 5 years, OS was 69%, and DFS was 59%.
Univariate analysis revealed that distant or lymph node metastasis at diagnosis,
surgical margins, and overall stage were statistically significant prognostic factors for
both OS and DFS. Multivariate analysis demonstrated that surgical margins remained
a statistically significant factor for DFS, while overall stage remained significant for OS.
Conclusions: This comprehensive analysis establishes surgical margins and overall
stage as independent prognostic factors in head and neck soft tissue sarcomas. The
findings demonstrate favorable long-term survival outcomes, with 5-year overall
survival reaching 69%. These results strongly support the critical importance of
achieving clear surgical margins and emphasize the necessity of accurate staging in
treatment planning. This evidence provides a robust foundation for clinical decisionmaking
in managing these rare but challenging neoplasms.